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Abstract
Background: Mass spectrometry for biological data analysis is an active field of research, providing an efficient
way of high-throughput proteome screening. A popular variant of mass spectrometry is SELDI, which is often used
to measure sample populations with the goal of developing (clinical) classifiers. Unfortunately, not only is the data
resulting from such measurements quite noisy, variance between replicate measurements of the same sample can
be high as well. Normalisation of spectra can greatly reduce the effect of this technical variance and further
improve the quality and interpretability of the data. However, it is unclear which normalisation method yields the
most informative result.
Results: In this paper, we describe the first systematic comparison of a wide range of normalisation methods,
using two objectives that should be met by a good method. These objectives are minimisation of inter-spectra
variance and maximisation of signal with respect to class separation. The former is assessed using an estimation
of the coefficient of variation, the latter using the classification performance of three types of classifiers on real-
world datasets representing two-class diagnostic problems. To obtain a maximally robust evaluation of a
normalisation method, both objectives are evaluated over multiple datasets and multiple configurations of baseline
correction and peak detection methods. Results are assessed for statistical significance and visualised to reveal
the performance of each normalisation method, in particular with respect to using no normalisation. The
normalisation methods described have been implemented in the freely available MASDA R-package.
Conclusion: In the general case, normalisation of mass spectra is beneficial to the quality of data. The majority
of methods we compared performed significantly better than the case in which no normalisation was used. We
have shown that normalisation methods that scale spectra by a factor based on the dispersion (e.g., standard
deviation) of the data clearly outperform those where a factor based on the central location (e.g., mean) is used.
Additional improvements in performance are obtained when these factors are estimated locally, using a sliding
window within spectra, instead of globally, over full spectra. The underperforming category of methods using a
globally estimated factor based on the central location of the data includes the method used by the majority of
SELDI users.
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Background
A wide range of mass spectrometry techniques is available,
of which Matrix-Assisted Laser Desorption and Ionisation
(MALDI) and Surface-Enhanced Laser Desorption and
Ionisation (SELDI) [1] coupled with Time-Of-Flight
(TOF) tubes are widely used for proteome screening. In
both of these techniques a biological sample of interest,
e.g., a serum sample, is applied to a plate or chip, left to
incubate and subsequently co-crystallised with a matrix
material. A laser is then fired at the co-crystallised mixture,
causing it to desorb. The energy of the laser beam is trans-
ferred via the matrix to the analyte sample, thereby ionis-
ing it. An electrical field causes the desorbed and ionised
material to fly through the TOF tube. Lower mass peptides
travel faster through the tube than higher mass peptides,
causing the former to arrive earlier at a detector placed at
the end of the flight tube. Using a quadratic equation, the
mass to charge ratio (m/z) of a peptide can be calculated.
Because of the indirect (i.e., via the matrix) ionisation,
laser desorption and ionisation is considered to be a
"soft" ionisation method. As a consequence, most pep-
tides will be single-charged, i.e., z = 1.
The main difference between MALDI and SELDI is that the
latter normally uses a chip with a chromatographic sur-
face, making the purification of the sample implicit. For
MALDI, the purification needs to be done before applica-
tion to the plate, for example through the use of chroma-
tographic beads. Data resulting from mass spectrometry
measurements usually contain a substantial amount of
noise and show large inter-measurement variation [2].
Technical variance in mass spectra can be caused by a
number of factors, including the pre-processing of sam-
ples in the wet-lab and the mass spectrometer itself. The
best way to get maximal power from a statistical analysis
is to minimise the level of experimental error and noise.
Variance introduced during the pre-processing stages
should therefore be minimised as much as possible using
strict lab protocols. Furthermore, it makes sense to per-
form multiple replicate measurements of the same
patient. Doing so will give a better estimation of the "true"
spectrum of a patient, leading to a better characterisation
of the population.
Independent of whether replicate measurements are per-
formed or not, normalisation is usually conducted in
order to increase comparability of spectra resulting from
different measurements. Normalisation of mass spectra
typically entails subtracting an (optional) offset and
dividing by a scaling factor. Such offset and scaling param-
eters can be defined and applied globally, over the full
spectrum, or locally, using a sliding window, encompass-
ing a contiguous subset of spectral positions. The ration-
ale behind this is that the global approach may be better
able to capture the general characteristics of the data,
whereas the local approach may be beneficial for spectra
with varying (mass-dependent) noise levels.
Although extensive effort has been devoted towards
understanding and modeling the noise [3,4] and variation
[5-7] observed in mass spectra, it is unclear which normal-
isation method is most favourable. Here we perform an
extensive comparison of 16 normalisation methods.
Please refer to the Methods section for an overview of the
methods evaluated. In a comparison of normalisation
methods one should employ a measure of the reduction
in inter-spectra variation after normalisation to assess the
performance of different normalisation methods. How-
ever, this may actually promote degradation of the signal
in case normalisation entails dividing the original spec-
trum by a quantity that is proportional to itself. In such a
case, the resulting coefficient of variance will be low,
although the amplitude of the remaining signal, will, of
course, be very low as well; a situation that is clearly
highly undesirable.
SELDI and MALDI are typically used for proteome profil-
ing with the goal of finding biomarkers capable of dis-
criminating between different classes of patients, for
instance between healthy controls and cancer variants. To
accomplish this, various classification techniques can be
used to find (sets of) peaks with maximal discriminatory
power. To safe-guard the presence of signal after normali-
sation, in this paper, classification performance is an
important measure to compare normalisation methods,
in addition to spectral variance. With the above in mind,
we define a good normalisation method to be one that
adheres to the following objectives:
1. minimises the variance between spectra;
2. maximises the classification signal, i.e., the association
of spectra with their respective class labels.
To assess the first objective, the coefficient of variance
between spectra is used. The second objective is measured
using the performance of three classifier, or "classifier-
like", systems. These are the Globaltest, the Support Vec-
tor Machine (SVM) with a radial basis kernel and a deci-
sion tree (CART).
Note that we assess both objectives separately, yielding
two performance indicators, instead of combining them
to yield one objective score. The reason for this is that the
used objectives are partly conflicting, in the sense that a
reduction in variance does not neccessarily lead to an
improvement in classification performance. This makes it
non-trivial to combine them in a straight-forward manner
and forces one to attach weights to each of them, as also
illustrated in Additional file 1. Instead of choosing theseBMC Bioinformatics 2008, 9:88 http://www.biomedcentral.com/1471-2105/9/88
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weights ourselves, we prefer to let the reader decide which
of the two objectives is most important.
Results and Discussion
For this comparison, four different real-world datasets
representing two-class diagnostic problems have been
analysed, before and after normalisation. For robustness,
the pre-processing of spectra was performed using 42 dif-
ferent configurations, the product of seven methods for
baseline correction and six peak detection approaches.
Normalisation of spectra using the 16 methods under
study was carried out after baseline correction and prior to
peak detection.
For each of the 42 configurations, both objectives, i.e.,
inter-spectra variance minimisation and classification per-
formance maximisation, were assessed for each of the nor-
malisation methods as well as for unnormalised data. This
results for each normalisation method in two vectors of
(ranked) scores, one for each objective, across all 42 pre-
processing approaches and four datasets. Please refer to
the Methods section for a detailed explanation of how
these vectors (Equations 6 and 7) are obtained.
We used non-parametric paired Wilcoxon signed rank
tests on these vectors to compare all normalisation meth-
ods in terms of the two objectives. Paired tests have been
used to control for effects from the baseline correction
methods, peak detection approaches and datasets used.
We used one-tailed tests to obtain information on relative
differences in scores between any two normalisation
methods, i.e., whether one method is better than the next,
an indicator of the performance of one method versus
another. Using two-tailed tests would only provide us
with information on whether they perform significantly
different. Figure 1 depicts the results of this analysis, for
both of the objectives. Some methods perform consist-
ently poorly for both objectives (e.g., "Local zero
median"). Others show a large difference in performance
between the two objectives. A good example of this is the
"Local min range" method, which reduces the variance
between spectra more efficiently than any other method,
however this has consequences for the classification per-
formance, which is very poor compared to other methods.
This illustrates the shortcoming of exclusively minimising
the inter-spectra variance and the need for a second objec-
tive to safe-guard signal quality. However, note that this
second objective should also not be used exclusively,
because it is biased towards the classification methods
Relative differences between methods in terms of both objectives Figure 1
Relative differences between methods in terms of both objectives. Plot indicating relative differences between meth-
ods in terms of a. inter-spectra variance minimisation and b. classification performance maximisation. A coloured cell indicates 
that the ranked scores of the method in the row are significantly better than those of the method in the column, with the col-
our of the cell corresponding to the order of magnitude of the p-value obtained using paired Wilcoxon signed rank tests. Rows 
are sorted by the number of coloured cells, giving an indication of relative score differences between methods.
a. Inter−spectra variance minimisation
L
o
c
a
l
 
z
e
r
o
 
m
e
d
i
a
n
N
o
 
n
o
r
m
a
l
i
s
a
t
i
o
n
G
l
o
b
a
l
 
m
e
d
i
a
n
 
M
A
D
G
l
o
b
a
l
 
m
e
d
i
a
n
 
q
u
a
n
t
i
l
e
G
l
o
b
a
l
 
z
e
r
o
 
m
e
d
i
a
n
L
o
c
a
l
 
z
e
r
o
 
m
e
a
n
G
l
o
b
a
l
 
z
e
r
o
 
M
A
D
G
l
o
b
a
l
 
z
e
r
o
 
m
e
a
n
G
l
o
b
a
l
 
m
e
a
n
 
S
D
G
l
o
b
a
l
 
z
e
r
o
 
S
D
L
o
c
a
l
 
m
e
d
i
a
n
 
q
u
a
n
t
i
l
e
L
o
c
a
l
 
m
e
d
i
a
n
 
M
A
D
L
o
c
a
l
 
m
e
a
n
 
S
D
L
o
c
a
l
 
z
e
r
o
 
M
A
D
G
l
o
b
a
l
 
m
i
n
 
r
a
n
g
e
L
o
c
a
l
 
z
e
r
o
 
S
D
L
o
c
a
l
 
m
i
n
 
r
a
n
g
e
Local zero median
No normalisation
Global median MAD
Global median quantile
Global zero median
Local zero mean
Global zero MAD
Global zero mean
Global mean SD
Global zero SD
Local median quantile
Local median MAD
Local mean SD
Local zero MAD
Global min range
Local zero SD
Local min range
b. Classification performance maximisation
G
l
o
b
a
l
 
m
i
n
 
r
a
n
g
e
G
l
o
b
a
l
 
z
e
r
o
 
m
e
a
n
G
l
o
b
a
l
 
z
e
r
o
 
m
e
d
i
a
n
L
o
c
a
l
 
m
i
n
 
r
a
n
g
e
L
o
c
a
l
 
z
e
r
o
 
m
e
a
n
L
o
c
a
l
 
z
e
r
o
 
m
e
d
i
a
n
N
o
 
n
o
r
m
a
l
i
s
a
t
i
o
n
G
l
o
b
a
l
 
m
e
d
i
a
n
 
M
A
D
G
l
o
b
a
l
 
m
e
d
i
a
n
 
q
u
a
n
t
i
l
e
G
l
o
b
a
l
 
z
e
r
o
 
M
A
D
G
l
o
b
a
l
 
z
e
r
o
 
S
D
L
o
c
a
l
 
z
e
r
o
 
S
D
G
l
o
b
a
l
 
m
e
a
n
 
S
D
L
o
c
a
l
 
m
e
a
n
 
S
D
L
o
c
a
l
 
m
e
d
i
a
n
 
M
A
D
L
o
c
a
l
 
m
e
d
i
a
n
 
q
u
a
n
t
i
l
e
L
o
c
a
l
 
z
e
r
o
 
M
A
D
Global min range
Global zero mean
Global zero median
Local min range
Local zero mean
Local zero median
No normalisation
Global median MAD
Global median quantile
Global zero MAD
Global zero SD
Local zero SD
Global mean SD
Local mean SD
Local median MAD
Local median quantile
Local zero MAD
< 0.001
< 0.005
< 0.01
< 0.05BMC Bioinformatics 2008, 9:88 http://www.biomedcentral.com/1471-2105/9/88
Page 4 of 11
(page number not for citation purposes)
employed and is dependent on the actual datasets used,
unlike the inherently unbiased first objective.
Comparison to no normalisation
Another way of looking at these results is by comparing all
normalisation methods to the case where no normalisa-
tion is performed, i.e., the columns indicated by 'No nor-
malisation' in Figure 1. Figure 2 contains a quadrant plot,
illustrating the performance of each normalisation
method against unnormalised data in terms of both
objectives, in more detail. The lower left area indicates
improvement in both objectives, the lower right area
improvement in variance reduction but a deterioration in
classification performance and the upper right area a dete-
rioration in both objectives. The shaded bands along the
lines where p = 1 indicate regions where p ≥ 0.05, i.e.,
where differences in scores between the methods in these
regions and using unnormalised data are not significant.
As becomes apparent from the figure, the majority of nor-
malisation methods lie within the (non-shaded) lower
left region, indicating that they significantly outperform
the case when no normalisation is used. An interesting
observation here is that the default normalisation method
used by most SELDI users ("Global zero mean") slightly
reduces the variance but does not improve classification
performance significantly with respect to unnormalised
data.
Per-classifier performance
In order to study what the contribution of individual clas-
sifiers is to the overall results, we repeated the statistical
analysis for each classifier separately. Since the classifiers
employed were chosen from a wide range of classification
modalities, this analysis will yield insight into the effect of
the choice of classifier on the overall ranking of the meth-
ods. The results are depicted in Figure 3. We notice that
some normalisation methods cause signal degradation for
SVM, placing them in the lower-right area of the quadrant,
Significance of the difference in objective scores Figure 2
Significance of the difference in objective scores. Quadrant plot showing the significance of the difference in objective 
scores between each normalisation method and unnormalised data. Each normalisation method is represented by a different 
symbol, global variants being annotated with an additional circle. The axes represent p-values of the statistical analysis 
described earlier, for classification performance and variance reduction on the x-axis and y-axis, respectively. The point (1, 1) 
indicates the position of unnormalised data. The region in which a method lies represents its performance for each objective 
with respect to using no normalisation.
Quadrant plot: Classification vs. variance
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albeit not significantly worse than employing no normal-
isation. We further notice that none of the methods per-
form significantly better than using no normalisation for
all classifiers. This is largely due to the CART classifier,
which has most of the normalisation methods in the
(non-significant) shaded areas. As indicated by the range
of p-values on the x-axes of the quadrant plots, the
increase in classification performance due to normalisa-
tion is much lower for CART than it is for the Globaltest
and SVM, suggesting that CART is less sensitive to normal-
isation or is simply incapable of finding the 'good' fea-
tures, and can therefore not exploit the features where
normalisation does show an effect. A paired one-tailed
Wilcoxon signed rank test on the raw, i.e., unranked, cross
validation classification errors yielded by SVM and CART
reveals that SVM performs significantly better than CART
overall (p = 2.05 × 10-67), suggesting the latter.
Global vs. local normalisation methods
The normalisation methods we studied employ two
parameters, an offset and a scaling parameter. The meth-
ods can be divided into two groups, depending on
whether they are based on global or on local estimates of
characteristics of the data. To study whether this parame-
ter (global vs. local) has a significant effect on the two per-
formance objectives, we compared the performance of
these two groups of methods. This was done by pairing
the performance ranks obtained for local methods with
those of their global counterparts, e.g., "Local zero mean"
was paired with "Global zero mean", for each of the two
objectives. We then used the Wilcoxon signed rank test to
test the null-hypothesis that the number of cases in which
a method from one group outperforms its paired method
from the other group is equal to the number of cases in
which the opposite is the case.
We used one-tailed tests to be able to assess which of the
two groups performed statistically significantly better.
This resulted in two p-values per objective, which were
corrected for multiple testing using the Bonferroni
method. Figure 4a shows these values, also indicating the
used pairings between local and global methods. Global
methods are shown in black and local methods in red. We
see that for both objectives local methods provide an
advantage over global methods (p = 0.0391). Note that
this may not be obvious from looking at Figure 4a alone,
particularly for the classification performance, because
the placement of methods in this figure indicates the per-
formance relative to using no normalisation.
Offset and scaling parameters
A number of the normalisation methods studied use a
zero-valued offset parameter. To study the influence of
this on the performance, we again divided the methods
into two groups, i.e., methods that employ a non-zero
parameter versus those for which this parameter has been
set to zero. We used a two-sample Wilcoxon rank sum
(i.e., Mann-Whitney U) test to test the null-hypothesis
that the two groups outperform the case in which no nor-
malisation is performed, an equal number of times. As
before, we tested both tails separately for both objectives,
resulting in four p-values, again corrected for multiple
testing using the Bonferroni method. Figure 4b shows
these values, indicating no significant effect for either of
the two objectives.
The same analysis was done for the scaling parameter,
which can also be divided into two groups; one contain-
ing methods that use the central location of the data (i.e.,
mean or median) and another containing methods that
use some measure of dispersion of the data around that
central location (i.e., standard deviation, median absolute
Significance of the difference in objective scores, for each classifier separately Figure 3
Significance of the difference in objective scores, for each classifier separately. Quadrant plots showing the signifi-
cance of the difference in objective scores, for each classifier separately, between each normalisation method and unnormal-
ised data. a. Globaltest, b. SVM, c. CART.
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Quadrant plot: SVM
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Quadrant plot: CART
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deviation or (quantile) range). Figure 4c shows that there
is a significant difference here; in terms of both variance
reduction (p = 5.23 × 10-6) and classification performance
(p = 1.15 × 10-6) it is beneficial to choose a scaling param-
eter based on the dispersion of the data.
Conclusion
We have performed a systematic comparison of 16 nor-
malisation methods for (SELDI-TOF) mass spectrometry
data. For robustness, a large number (42) of configura-
tions for baseline correction and peak detection methods
was used, as well as multiple datasets. We used two objec-
tives to assess the benefit of applying a particular normal-
isation method, namely minimisation of inter-spectra
variance and maximisation of classification performance.
The latter has proven to be very helpful in safe-guarding
against methods that reduce the variance between spectra
but at the same time do not improve, or even worsen, the
amount of meaningful signal left after normalisation.
We have shown that in the general case, normalisation of
mass spectra is beneficial to both objectives; most meth-
ods we compared performed significantly better than the
case in which no normalisation was used. We have shown
that normalisation methods that scale spectra by a factor
based on the dispersion (e.g., standard deviation) of the
data clearly outperform those where a factor based on the
central location (e.g., mean) is used. Additional improve-
ments in performance are obtained when these factors are
estimated locally, using a sliding window within spectra,
instead of globally, over full spectra. The underperforming
category of methods using a globally estimated factor
based on the central location of the data includes the
method used by the majority of SELDI users, i.e., "Global
zero mean".
Methods
Normalisation methods
Mass spectra typically exhibit an artefact in the form of a
baseline drift, which can be removed by estimating and
subtracting it. Such baseline corrected spectra, denoted by
S, are the basis for normalisation. Normalisation involves
applying spectrum specific transformations to S. To prop-
erly describe normalisation methods, resulting in a nor-
malised spectrum N, we define the following model:
where  Θ and Δ denote offset and scaling parameters
respectively. Both of these parameters can be estimated
globally over a full spectrum or locally using a sliding win-
dow, which encompasses a contiguous subset of spectral
positions. In the former case, Θ and Δ assume scalar val-
ues, while in the latter case, Θ and Δ are vectors of length
|S|, i.e., the number of measurement points in the spec-
trum.
Table 1 contains an overview of the normalisation meth-
ods evaluated in this study, expressed in terms of combi-
nations of offset and scaling parameters. These have been
chosen based on methods described in the literature and
on pragmatic reasoning. Methods already used in the field
of mass spectrometry have been complemented with
more generic methods, including simple variance stand-
ardisation.
N
S
=
−Θ
Δ
, (1)
Detailed analyses of different subgroups of methods Figure 4
Detailed analyses of different subgroups of methods. Quadrant plots showing more detailed analyses of different sub-
groups of methods. Elements are coloured by group; black vs. red, as indicated in the figure titles. Black p-values indicate the 
significance with which "black" methods outperform the "red" methods and red p-values the opposite. Lines between elements 
indicate a pairing of variables for the statistical tests used. The following groupings are used: a. global vs. local estimations of 
normalisation parameters, b. non-zero vs. zero offsets and c. scaling using the central location vs. the dispersion of data.
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The last column of Table 1 contains, when possible, cita-
tions of studies in which the normalisation methods were
used. Note that for each method the global and local var-
iants have been used, resulting in a total of 16 methods.
Additional file 2 contains formal definitions of the nor-
malisation methods.
The first method in Table 1 ("zero mean") is a derivation
of the method as implemented in the software supplied
with SELDI-TOF-MS machines. Strictly speaking, this soft-
ware (Ciphergen©  ProteinChip Software 3.1) uses the
mean intensity per spectrum to scale individual spectra
and subsequently re-scales all spectra by the mean inten-
sity across all spectra. Because this second scaling is done
using a constant scale factor for all spectra, it can easily be
left out, as we do here. Although this second scale factor is
constant for one normalisation run, it is completely
dependent on all spectra, i.e., on their means. This makes
it hard to introduce new samples at a later stage or test any
built classifier on another dataset. For this reason we only
focus on normalisation factors calculated per single spec-
trum.
As an alternative to using the mean intensity as a scale fac-
tor, the median can be used (i.e., method "zero median").
Some studies [8] suggest this may be more robust against
outlying peaks.
Another way of normalising spectra is by using the data
dispersion, such as the standard deviation (methods "zero
SD" and "mean SD"), the median absolute deviation
(methods "zero MAD" and "median MAD") or ranges of
the data. Method "min range" essentially re-scales the data
to the interval [0, 1], either globally or in a local window.
As a more robust alternative to this, method "median
quantile" uses quantiles of the data.
The citation for method "min range" is parenthesised in
Table 1 because it does not strictly follow the normalisa-
tion described. In that particular study, normalisation is
performed over random subsets of (binned) intensity val-
ues instead of over all values (globally) or sliding win-
dows of adjacent values (locally).
Objective 1: inter-spectra variance
Given the linear relationship between means and stand-
ard deviations of peaks (illustrated in last section of Addi-
tional file 3), a reasonable measure to compare inter-
spectra variation between methods is the coefficient of
variation (CV). Defined as the ratio between the standard
deviation and the mean   it represents a more
scale-independent estimation of the variance. However, it
may also yield very unstable results for mean values
around zero. For this reason, we use an alternative way of
computing the CV, adopted from [8]:
which is essentially the slope of a regression line through
the origin in a scatter plot of s vs. μ, such as shown by the
dashed line in the figure in Additional file 3.
A sensible way to estimate inter-spectra variance after nor-
malisation would be to inspect the CV calculated over a
number of artificially spiked-in peaks and between same-
sample replicates. In (existing) real-world datasets how-
ever, technical replicates may not be present, let alone arti-
ficial spiking peaks. We hypothesised that the CV
calculated over all peaks and all available spectra (from all
classes) should be a reasonable approximation of the
average same-sample replicate CV calculated over spiking
peaks only. This is indeed the case, proven by a high Pear-
son correlation (0.98) between the CVs calculated over
the four spiking peaks and over all peaks present in the
spectra of this dataset. For this reason, it is justified to use
the CV calculated over all peaks. This allows us to use mul-
tiple datasets in our comparison of normalisation meth-
ods, including datasets lacking spiked-in peptides and/or
technical replicates.
Objective 2: classification performance
In order to assess class separation, and more specifically
how it changes under the influence of different normali-
sation methods, we employ a number of classifiers or clas-
sifier-like systems. We employed a single classifier at a
time in combination with the variance objective. All clas-
sifier analyses were performed using R and various pack-
() CV = s
m
CV =
∑
∑
sii i
i i
m
m2 , (2)
Table 1: Normalisation methods used in the comparison. 
Normalisation methods used in the comparison. Offset and 
scaling parameters are used as in Equation 1. Note that for each 
method these parameters are estimated globally as well as 
locally and evaluated separately. Formal definitions of these 
methods can be found in Additional file 2.
No Offset (Θ) Scaling (Δ) Working name Citation
10 m e a nZero mean [15,16]
20 m e d i a n Zero median [8]
30 s d Zero SD
40 m a d Zero MAD
5m e a n s d Mean SD
6m e d i a n m a d Median MAD
7m e d i a n i q r Median quantile [17]
8 min range Min range ([18])BMC Bioinformatics 2008, 9:88 http://www.biomedcentral.com/1471-2105/9/88
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ages that are available for it, and below we elaborate on
each of the employed systems.
The Globaltest
The Globaltest [9] tests the association of groups of fea-
tures with a given outcome. Simply put, it tests whether
the normalized sum of the correlation coefficients result-
ing from correlating the peak heights and the class label is
sufficiently high to reject the null hypothesis that there is
no association between the peak heights and the class
label. It is not a classifier, in the sense that it does not out-
put a mapping to assign new samples to one of the out-
come classes. It does, however, give an indication of the
quality of a dataset with respect to class separation. On
top of that, it makes minimal assumptions about the data
and has no parameters to be set. The result of using the
Globaltest is a single p-value for each group of features,
where a group can be defined as all features in a dataset or
a subset thereof. Here, we apply this test to all peaks found
in a normalised mass spectrum. The globaltest package
was used as an implementation of the Globaltest.
Support Vector Machine (SVM) with radial basis kernel
A SVM [10] is a classifier that is widely used because of its
generally good performance in complex classification
problems and especially in applications, such as the prob-
lem being studied here, where the number of features is
larger than the total number of samples. In essence, it is a
classifier in linear space, however transformation to a
non-linear space is achieved by using a non-linear kernel,
such as the radial basis kernel, as we do here. We used the
implementation provided by the e1071 package. To assess
the performance of this classifier we use the leave-one-out
cross validation error. This was implemented using the
ipred package.
Classification And Regression Trees (CART)
CART [11] is an algorithm that is widely used within the
SELDI community because it is implemented in the soft-
ware that comes with the mass spectrometer itself and
allows for easy interpretation of results. Trees were
obtained by a two-step process, making use of the rpart
package. Initially, large trees are grown using the Gini
index for node impurity. Resulting trees are then, again
using a leave-one-out cross validation approach, pruned
back to the number of nodes at which the improvement
in fit is not significant anymore. This process has the goal
of avoiding overfitting. Like with the SVM, we employ the
leave-one-out cross validation error to assess the perform-
ance of built classifiers.
Datasets
For robustness, the comparison of normalisation meth-
ods has been performed using a total of four SELDI data-
sets.
￿ The first dataset is the result of an experiment designed
and executed specifically for this study. It is the dataset
used to study the relation between mean and standard
deviation of peak intensities. For this dataset, real-world
serum samples from patients suffering from colorectal
cancer (four samples) and controls (four samples) have
been artificially spiked with additional peptides. For each
sample a total of 10 technical replicates was obtained,
yielding a total of 80 spectra, 40 per class. Please refer to
Additional file 3 for a more elaborate discussion on (the
preparation of) this dataset.
￿ The second and third datasets resulted from an earlier
study [12] concerned with finding biomarkers in human
serum to differentiate between colorectal cancer patients
and controls. The datasets consist of SELDI measurements
of serum samples from 37 colorectal cancer patients vs. 31
controls and 40 colorectal cancer patients vs. 49 controls.
Detailed information on the used experimental setup and
pre-processing methods can be found in [12].
￿ The fourth dataset is from the public repository of the
Critical Assessment of Microarray Data Analysis
(CAMDA) conference 2006 [13]. In this case, the dataset
is the result of measuring serum samples of patients suf-
fering from chronic fatigue syndrome as well as control
persons, with 62 and 64 samples in each class, respec-
tively. Specifically, the second liquid chromatography
fraction of the CM10 CAMDA dataset was used. The used
pre-processing protocols can be obtained from the
CAMDA website.
Spectrum pre-processing
All pre-processing of spectra was done using the R statisti-
cal software with the MASDA R-package. Pre-processing
includes correcting the baseline effect of raw spectra, nor-
malisation and peak detection, filtering and clustering.
We used seven different methods of correcting the base-
line of raw spectra before normalisation. These methods
include the one implemented in the PROcess R-package,
the method used by the manufacturer of SELDI machines
and methods based on various smoothing approaches.
After normalisation, peaks are detected in individual spec-
tra, effectively by detecting changes in the first derivative
of the intensity curve. This is followed by a process in
which peaks are filtered by using estimated noise thresh-
olds, depending on the parameter settings. During the
comparison, six different parameter settings were used for
robustness. These settings ranged from using no filtering
at all to filtering out all peaks below a local noise thresh-
old estimated by a robust local estimator plus five times
its median absolute deviation (MAD).BMC Bioinformatics 2008, 9:88 http://www.biomedcentral.com/1471-2105/9/88
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Please refer to Additional file 4 for a more detailed
description of the baseline correction and peak detection
methods used.
After peak detection and filtering, peaks from different
spectra are clustered together using complete linkage hier-
archical one-dimensional clustering with a configurable,
mass dependent, cut-off point. By default, this point is
0.3% of the peak m/z value. This mass dependent value is
turned into a constant by log10 transforming the m/z val-
ues of detected peaks. For the default value of 0.3%, this
yields a cut-off point roughly equal to 0.0013. Resulting
peak-clusters, containing one peak per processed spec-
trum, are used as units in subsequent analyses.
The MASDA mass spectrometry data analysis R-package is
freely available [14]. All code to process the datasets is
included as Additional file 5.
Ranked score vector calculation
Figure 5 gives an overview of the workflow used to obtain
objective scores for all datasets, normalisation methods
and configurations of pre-processing approaches. We
employed seven different methods for baseline correction
and six different peak detection approaches, combining
them results in 42 configurations. For each pre-processing
configuration c and normalisation method n we obtained
an estimate of the coefficient of variation and three classi-
fication scores (i.e., for Globaltest, SVM and CART). Fig-
ure 6 shows the structure of the resulting score tables for
each of these four cases, for one dataset d. Note that we
obtain such a set of score tables for each dataset used. Also
note that we added an extra reference normalisation
method entitled "No normalisation", which allows a
comparison of the 16 normalisation methods with the
case where no normalisation is performed.
Each score table   is converted into a rank table   of
identical dimensions by calculating column-wise ranks,
i.e., normalisation methods are ranked per configuration
c  of baseline correction and peak detection methods.
More formally:
To assess both objectives, i.e., variance minimisation and
class separation maximisation, we define two vectors per
normalisation method n and dataset d containing all rele-
vant ranks:
where [a, b] represents the concatenation of two row vec-
tors. Final vectors   and   containing informa-
tion from all four datasets are obtained by row-wise
concatenation and are the basis for the statistical analysis:
We use a non-parametric paired Wilcoxon signed rank test
to compare two normalisation approaches, separately for
the two objectives. Tests are performed on all possible
pairings of normalisation methods, to assess whether
rankings are significantly different between methods, irre-
spective of the used baseline correction method, peak
detection approach and dataset. More specifically, we use
one-tailed tests in order to obtain information on relative
performance differences between normalisation methods.
SX
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(3)
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Schematic representation of the computational workflow Figure 5
Schematic representation of the computational workflow. Schematic representation of the computational workflow 
used for the comparison. Baseline correction, normalisation and peak detection are implemented in the MASDA R-package. 
Both objectives used for the comparison are estimated for each dataset d, normalisation method n and configuration c of base-
line correction and peak detection parameters. For each tuple (d, n, c), this results in a score  (n, c) for variance and  (n, 
c), (n, c), and  (n, c) for classification performance.
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Bonferroni multiple testing corrected p-values were
obtained by multiplying the raw p-values with a correc-
tion factor equal to the number of normalisation methods
employed, i.e., 17.
All code to analyse the datasets as described above, and to
exactly generate the figures used in this paper, is included
as Additional file 6.
Construction of quadrant plots
Quadrant plots (Figures 2, 3 and 4) aim to visualise the
performance of normalisation methods, simultaneously
for the two objectives. For each objective, we use two one-
tailed tests to assess whether the performance of a partic-
ular normalisation method is significantly better or worse
than when using no normalisation. We employed one-
tailed tests, since we wanted to test the directionality of
the association, and then correct for multiple testing.
Because we are interested in differences between normali-
sation methods, we only use the lowest of the two p-val-
ues obtained from the two one-tailed tests per objective.
For each normalisation method, we then plot a symbol
representing it in the quadrant plot, using the two result-
ing p-values (one for each objective) as coordinates.
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Formal definitions of normalisation methods. PDF-file containing for-
mal definitions of the normalisation methods included in this study.
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Processing protocol used for spiked dataset. PDF-file containing an 
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standard deviation.
Click here for file
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Structure of tables containing scores resulting from different measurements Figure 6
Structure of tables containing scores resulting from different measurements. Structure of tables containing scores 
resulting from different measurements on a dataset d, i.e., estimations of the coefficient of variance ( ) Globaltest p-values 
( ) and leave-one-out cross validation errors for SVM ( ) and CART ( ). Each table consists of 17 rows, repre-
senting the 16 normalisation methods (global and local variants) and 'no normalisation'. There are 42 columns in each table, 
one for each configuration of baseline correction (7) and peak detection (6) approaches.
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